Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 22 July 2025, 08:00 HKT/SGT
Share:
    

Source: ShrimpTech JIRCAS, Inc
ShrimpTech JIRCAS and IMT Engineering Announce Strategic Collaboration to Advance Land-Based Aquaculture

TOKYO, July 22, 2025 - (JCN Newswire) - ShrimpTech JIRCAS, Inc. (Tsukuba City, Ibaraki Prefecture, CEO: Dr. Marcy Wilder) and IMT Engineering Co., Ltd. (Minato-ku, Tokyo, CEO: Mr. Motoki Okada) today announced the signing of a Letter of Intent (LOI) to pursue strategic collaboration in the field of land-based re-circulating aquaculture.

Through mutual trust and a shared history of over 20 years of joint R&D as co-inventors of the Indoor Shrimp Production System “ISPS”, the two companies plan to contribute expertise and resources to support the advancement of sustainable fisheries production. This collaboration will focus on both basic and applied research, feasibility studies, and the commercialization of new technologies to promote the growth of land-based shrimp aquaculture in Japan and internationally.

Key aspects of the partnership include:

  • IMT Engineering will provide technical support, including site surveys and facility design.
  • ShrimpTech JIRCAS will focus on research and technology commercialization.
  • The companies will explore joint business activities in response to potential client needs.
  • HR exchange and cultivation of research staff to further promote innovation.

"We are honored to work alongside IMT Engineering as we take new steps towards making land-based shrimp culture more sustainable," said Dr. Marcy Wilder, CEO of ShrimpTech JIRCAS. "We believe this collaboration will allow both companies to leverage our strengths and deliver positive impact to the industry."

Both companies welcome inquiries from organizations and partners interested in sustainable aquaculture.

Contact information:
Dr. Marcy Wilder, https://shrimptech.co.jp/en/home;
Mr. Motoki Okada, https://www.imteng.co.jp/en




Topic: Press release summary
Source: ShrimpTech JIRCAS, Inc

Sectors: Water, Environment, ESG, Startups
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Honda Premieres a New Color Option for Four Large-size Outboard Motors at HISWA In-Water Boat Show 2025 in the Netherlands  
Wednesday, September 3, 2025 10:50:00 PM
Toyota Joins TOKYO H2 Project Aiming to Make Tokyo a Global Leader in Hydrogen  
Wednesday, September 3, 2025 9:39:00 PM
CENTRESTAGE celebrates a decade of style, Four days of fashion events open to all with fashion gurus leading inspiring sessions  
Sept 3, 2025 20:45 HKT/SGT
SERES Posts Robust H1 2025 Results: Revenue Hits CNY 62.4 Billion, Net Profit Up 81% to CNY 2.94 Billion, R&D Investment Soars nearly 155%  
Sept 3, 2025 16:43 HKT/SGT
Sichuan Neautus TCM Files for Hong Kong IPO to Accelerate Domestic and Global Expansion  
Sept 3, 2025 16:33 HKT/SGT
Focus Graphite Pilot Run Demonstrates Significant Increase in Large and Jumbo Flake Recovery at Lac Knife  
Sept 3, 2025 11:36 HKT/SGT
Honda Running Team Member, Nagiya Mori, Selected to Represent Japan in World Athletics Championships Tokyo 25 (WCH Tokyo 25) Men's 5000m Event  
Wednesday, September 3, 2025 11:30:00 AM
EdgePoint Launches Two More Digital Classrooms in East Malaysia under Its Connectivity for Communities Program  
Sept 3, 2025 11:05 HKT/SGT
PCG Launches AbbyPay, a POS-Free Digital Payment Solution  
Sept 3, 2025 10:43 HKT/SGT
Eisai Initiated Rolling Supplemental Biologics License Application to the U.S. FDA for LEQEMBI(R) IQLIK(TM) (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status  
Wednesday, September 3, 2025 10:32:00 AM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: